DexCom (NASDAQ:DXCM) Given New $103.00 Price Target at Canaccord Genuity Group
DexCom (NASDAQ:DXCM – Free Report) had its price target lifted by Canaccord Genuity Group from $99.00 to $103.00 in a research note released on Friday,Benzinga reports. They currently have a buy rating on the medical device company’s stock. Other analysts have also issued research reports about the company. Baird R W upgraded DexCom from a […]
DexCom (NASDAQ:DXCM – Free Report) had its price target lifted by Canaccord Genuity Group from $99.00 to $103.00 in a research note released on Friday,Benzinga reports. They currently have a buy rating on the medical device company’s stock. Other analysts have also issued research reports about the company. Baird R W upgraded DexCom from a […]
